Literature DB >> 20100060

Laparoscopic radical nephrectomy for T3b tumor.

Marcin Słojewski1, Adam Gołab, Piotr Petrasz, Andrzej Sikorski.   

Abstract

With the advancement of laparoscopic equipment and growing operational experience, the number of case reports or descriptions of series of nephrectomies performed in patients with the preoperative diagnosis of venous system involvement has become more frequent in the medical literature. In this article, we present the case of a laparoscopic nephrectomy performed with retroperitoneoscopic access for preoperatively diagnosed renal vein and vena cava thrombus. Operation time was 130 minutes and blood loss was 50 mL. The weight of the specimen was 460 g. The postoperative course was uncomplicated. The pathology report revealed pT3b clear cell cancer (Fuhrman grade 2) with negative margins on the venous cutting line.

Entities:  

Mesh:

Year:  2010        PMID: 20100060     DOI: 10.1089/lap.2009.0258

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  4 in total

1.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 2.  Minimally invasive radical nephrectomy: a contemporary review.

Authors:  Akbar N Ashrafi; Inderbir S Gill
Journal:  Transl Androl Urol       Date:  2020-12

3.  Laparoscopic radical nephrectomy for large renal tumor - a case report and technical considerations.

Authors:  Tomasz Szydełko; Krzysztof Tupikowski; Janusz Dembowski; Tadeusz Niezgoda; Adam Wojciechowski; Romuald Zdrojowy
Journal:  Cent European J Urol       Date:  2011-03-18

4.  Pure retroperitoneal laparoscopic radical nephrectomy and thrombectomy with delayed occlusion of the proximal inferior vena cava (DOPI) technique for renal tumor with level II-III venous tumor thrombus.

Authors:  Zhuo Liu; Peng Hong; Guodong Zhu; Li Zhang; Xun Zhao; Shiying Tang; Feilong Yang; Xiaojun Tian; Guoliang Wang; Shudong Zhang; Hongxian Zhang; Yi Huang; Chunxia Liu; Cheng Liu; Lulin Ma
Journal:  BMC Cancer       Date:  2021-05-27       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.